Your browser doesn't support javascript.
loading
Fibroblast Primary Cilia Are Required for Cardiac Fibrosis.
Villalobos, Elisa; Criollo, Alfredo; Schiattarella, Gabriele G; Altamirano, Francisco; French, Kristin M; May, Herman I; Jiang, Nan; Nguyen, Ngoc Uyen Nhi; Romero, Diego; Roa, Juan Carlos; García, Lorena; Diaz-Araya, Guillermo; Morselli, Eugenia; Ferdous, Anwarul; Conway, Simon J; Sadek, Hesham A; Gillette, Thomas G; Lavandero, Sergio; Hill, Joseph A.
Afiliação
  • Villalobos E; Departments of Internal Medicine (Cardiology) (E.V., A.C., G.G.S., F.A., K.M.F., H.I.M., N.J., N.U.N.N., A.F., H.A.S., T.G.G., S.L., J.A.H.), University of Texas Southwestern Medical Center, Dallas.
  • Criollo A; Advanced Center for Chronic Diseases, Faculty of Chemical Pharmaceutical Sciences and Faculty of Medicine (E.V., A.C., L.G., G.D.-A., S.L.), University of Chile, Santiago.
  • Schiattarella GG; Departments of Internal Medicine (Cardiology) (E.V., A.C., G.G.S., F.A., K.M.F., H.I.M., N.J., N.U.N.N., A.F., H.A.S., T.G.G., S.L., J.A.H.), University of Texas Southwestern Medical Center, Dallas.
  • Altamirano F; Advanced Center for Chronic Diseases, Faculty of Chemical Pharmaceutical Sciences and Faculty of Medicine (E.V., A.C., L.G., G.D.-A., S.L.), University of Chile, Santiago.
  • French KM; Research Institute for Odontology Sciences, Faculty of Odontology (A.C.), University of Chile, Santiago.
  • May HI; Departments of Internal Medicine (Cardiology) (E.V., A.C., G.G.S., F.A., K.M.F., H.I.M., N.J., N.U.N.N., A.F., H.A.S., T.G.G., S.L., J.A.H.), University of Texas Southwestern Medical Center, Dallas.
  • Jiang N; Departments of Internal Medicine (Cardiology) (E.V., A.C., G.G.S., F.A., K.M.F., H.I.M., N.J., N.U.N.N., A.F., H.A.S., T.G.G., S.L., J.A.H.), University of Texas Southwestern Medical Center, Dallas.
  • Nguyen NUN; Departments of Internal Medicine (Cardiology) (E.V., A.C., G.G.S., F.A., K.M.F., H.I.M., N.J., N.U.N.N., A.F., H.A.S., T.G.G., S.L., J.A.H.), University of Texas Southwestern Medical Center, Dallas.
  • Romero D; Departments of Internal Medicine (Cardiology) (E.V., A.C., G.G.S., F.A., K.M.F., H.I.M., N.J., N.U.N.N., A.F., H.A.S., T.G.G., S.L., J.A.H.), University of Texas Southwestern Medical Center, Dallas.
  • Roa JC; Departments of Internal Medicine (Cardiology) (E.V., A.C., G.G.S., F.A., K.M.F., H.I.M., N.J., N.U.N.N., A.F., H.A.S., T.G.G., S.L., J.A.H.), University of Texas Southwestern Medical Center, Dallas.
  • García L; Departments of Internal Medicine (Cardiology) (E.V., A.C., G.G.S., F.A., K.M.F., H.I.M., N.J., N.U.N.N., A.F., H.A.S., T.G.G., S.L., J.A.H.), University of Texas Southwestern Medical Center, Dallas.
  • Diaz-Araya G; Department of Pathology, Faculty of Medicine (D.R., J.C.R.), Pontifical Catholic University of Chile, Santiago.
  • Morselli E; Department of Pathology, Faculty of Medicine (D.R., J.C.R.), Pontifical Catholic University of Chile, Santiago.
  • Ferdous A; Advanced Center for Chronic Diseases, Faculty of Chemical Pharmaceutical Sciences and Faculty of Medicine (E.V., A.C., L.G., G.D.-A., S.L.), University of Chile, Santiago.
  • Conway SJ; Advanced Center for Chronic Diseases, Faculty of Chemical Pharmaceutical Sciences and Faculty of Medicine (E.V., A.C., L.G., G.D.-A., S.L.), University of Chile, Santiago.
  • Sadek HA; Department of Physiology, Faculty of Biological Sciences (E.M.), Pontifical Catholic University of Chile, Santiago.
  • Gillette TG; Departments of Internal Medicine (Cardiology) (E.V., A.C., G.G.S., F.A., K.M.F., H.I.M., N.J., N.U.N.N., A.F., H.A.S., T.G.G., S.L., J.A.H.), University of Texas Southwestern Medical Center, Dallas.
  • Lavandero S; Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis (S.J.C.).
  • Hill JA; Departments of Internal Medicine (Cardiology) (E.V., A.C., G.G.S., F.A., K.M.F., H.I.M., N.J., N.U.N.N., A.F., H.A.S., T.G.G., S.L., J.A.H.), University of Texas Southwestern Medical Center, Dallas.
Circulation ; 139(20): 2342-2357, 2019 05 14.
Article em En | MEDLINE | ID: mdl-30818997
BACKGROUND: The primary cilium is a singular cellular structure that extends from the surface of many cell types and plays crucial roles in vertebrate development, including that of the heart. Whereas ciliated cells have been described in developing heart, a role for primary cilia in adult heart has not been reported. This, coupled with the fact that mutations in genes coding for multiple ciliary proteins underlie polycystic kidney disease, a disorder with numerous cardiovascular manifestations, prompted us to identify cells in adult heart harboring a primary cilium and to determine whether primary cilia play a role in disease-related remodeling. METHODS: Histological analysis of cardiac tissues from C57BL/6 mouse embryos, neonatal mice, and adult mice was performed to evaluate for primary cilia. Three injury models (apical resection, ischemia/reperfusion, and myocardial infarction) were used to identify the location and cell type of ciliated cells with the use of antibodies specific for cilia (acetylated tubulin, γ-tubulin, polycystin [PC] 1, PC2, and KIF3A), fibroblasts (vimentin, α-smooth muscle actin, and fibroblast-specific protein-1), and cardiomyocytes (α-actinin and troponin I). A similar approach was used to assess for primary cilia in infarcted human myocardial tissue. We studied mice silenced exclusively in myofibroblasts for PC1 and evaluated the role of PC1 in fibrogenesis in adult rat fibroblasts and myofibroblasts. RESULTS: We identified primary cilia in mouse, rat, and human heart, specifically and exclusively in cardiac fibroblasts. Ciliated fibroblasts are enriched in areas of myocardial injury. Transforming growth factor ß-1 signaling and SMAD3 activation were impaired in fibroblasts depleted of the primary cilium. Extracellular matrix protein levels and contractile function were also impaired. In vivo, depletion of PC1 in activated fibroblasts after myocardial infarction impaired the remodeling response. CONCLUSIONS: Fibroblasts in the neonatal and adult heart harbor a primary cilium. This organelle and its requisite signaling protein, PC1, are required for critical elements of fibrogenesis, including transforming growth factor ß-1-SMAD3 activation, production of extracellular matrix proteins, and cell contractility. Together, these findings point to a pivotal role of this organelle, and PC1, in disease-related pathological cardiac remodeling and suggest that some of the cardiovascular manifestations of autosomal dominant polycystic kidney disease derive directly from myocardium-autonomous abnormalities.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rim Policístico Autossômico Dominante / Fibroblastos / Miocárdio Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Circulation Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rim Policístico Autossômico Dominante / Fibroblastos / Miocárdio Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Circulation Ano de publicação: 2019 Tipo de documento: Article